Annexon (ANNX) Times Interest Earned (2019 - 2026)
Annexon's (ANNX) quarterly Times Interest Earned came in at -$1.44 in Q1 2026, up 64.98% year-on-year from -$0.87 in Q1 2025, and up 50.59% quarter-over-quarter from -$2.92 in Q4 2025.
Annexon (ANNX) Times Interest Earned (2019 - 2026) Analysis & Trends
Annexon's Times Interest Earned history runs 8 years deep, the most recent figure standing at -$1.44 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 64.98% year-over-year to -$1.44 in Q1 2026; TTM through Mar 2026 was -$6.42, a 51.07% increase from a year earlier, with the FY2025 full-year figure at -$0.96, down 13.02% from the prior year.
- Times Interest Earned grew to -$1.44 in Q1 2026 per ANNX's latest filing, from -$2.92 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.23 in Q4 2023 and bottomed at -$12.93 in Q4 2024.
- The 5-year median for Times Interest Earned is -$1.44 (2026), against an average of -$3.53.
- Across the five-year window, Times Interest Earned jumped 97.92% in 2023 and plunged 5541.36% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$11.02 in 2022, then soared by 97.92% to -$0.23 in 2023, then plunged by 5541.36% to -$12.93 in 2024, then soared by 77.44% to -$2.92 in 2025, then soared by 50.59% to -$1.44 in 2026.
- Per Business Quant, the three latest ANNX Times Interest Earned figures stand at -$1.44 (Q1 2026), -$2.92 (Q4 2025), and -$10.15 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | -1.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.44 |
| Dec 31, 2025 | -2.92 |
| Sep 30, 2025 | -10.15 |
| Jun 30, 2025 | -6.32 |
| Mar 31, 2025 | -4.11 |
| Dec 31, 2024 | -12.93 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | -0.82 |
| Mar 31, 2024 | -0.68 |
| Dec 31, 2023 | -0.23 |
| Sep 30, 2023 | -0.79 |
| Jun 30, 2023 | -0.83 |
| Mar 31, 2023 | -2.97 |
| Dec 31, 2022 | -11.02 |
| Sep 30, 2022 | -0.74 |
| Jun 30, 2022 | -2.38 |
| Mar 31, 2022 | -0.70 |
| Dec 31, 2021 | -3.68 |
| Sep 30, 2021 | -1.19 |
| Jun 30, 2021 | -0.60 |